The Centre for Children and Young People's Cancer (CCC) serves as the focal point of basic, translational and clinical paediatric oncology research at the ICR and The Royal Marsden.

The Institute of Cancer Research, London, has welcomed the approval of a new combination of two drugs for a rare form of ovarian cancer by the US regulatory body the Food and Drug Administration (FDA) ...

The Institute of Cancer Research, London, strongly welcomes the decision by NICE to recommend that the targeted drug olaparib can be used for locally advanced or metastatic breast cancer. The ...

Two decades ago, a pivotal exchange between two scientists sparked a scientific and medical revolution. Professor Alan Ashworth, then Director of the Breast Cancer Now Toby Robins Research Centre at ...

Sally Steadman-South, a mother of two from Sheffield, was diagnosed with melanoma in 2014 at the age of 34, after visiting the GP about a small mole on her chest. “By the time I’d had the operation to ...

Each year approximately 2000 children are diagnosed with cancer in England and they receive a range of treatments including surgery, chemotherapy, radiotherapy, immunotherapy, and stem cell/bone ...

Elen Hughes was first diagnosed with primary invasive lobular breast cancer in 2008 at the age of 37. Eight years later, her cancer returned and spread, and she has been on a rollercoaster journey ...

Radiotheranostics is an exciting new field that has the potential to transform how cancers are detected and treated. Robbie Lockyer finds out more. Radiotheranostics, a groundbreaking approach that ...

Scientists have worked out how a protective element of our DNA helps prevent an abnormal genetic event that can lead to cells becoming cancerous. They have shown exactly how telomeres – the protective ...

The overuse of CT scans could cause over 100,000 cases of cancer in the US – with almost 10,000 cases in children, researchers have warned. According to a new modelling study, published in the journal ...

New research has provided insight into the biological mechanisms that may contribute to poor outcomes in certain cases of neuroblastoma – a cancer that develops in nerve tissue and primarily affects ...

Scientists have developed a revolutionary AI ‘fingerprint’ technology that can accurately show how cancer cells respond to new drugs, by simply observing changes to their shape. The new technology, ...